RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Chitosan nanoparticles-encapsulated cannabis extracts and their antimicrobial potential against skin pathogens
[EN] Cannabis compounds are well-known for their therapeutic applications in the treatment of various health issues. These substances, mainly cannabinoids, are known for their antimicrobial properties and ability to interact with various cells through endocannabinoid receptors. However, the limitations of cannabis extract, particularly its viscosity, stickiness, and low bioavailability when applied topically, limit its use in dermatology. To enhance topical applications for treating bacterial infections and dermatophytosis, cannabis extracts were encapsulated in chitosan nanoparticles, an easily accessible and cost-effective. Cannabis extracts were prepared from three cannabis strains differing in content of major cannabinoids, namely Chocolope (THCA-A), Jonas 1 (CBDA), and Hemp G (CBGA), and subsequently were encapsulated in chitosan nanoparticles. The resulting particles were characterized, and antimicrobial and cytotoxic activity was evaluated. The mean size of particles ranged from 89.1 +/- 24.8 nm for empty nanoparticles to 355.6 +/- 101.6 nm for particles containing Hemp G extract. Considering the extract:chitosan ratio (1:10 w/w, 1:20 w/w respectively) and the encapsulation efficiency (EE) range from 44.65 +/- 4.39% to 94.44 +/- 0.93%, total amount of extracts encapsulated in chitosan nanoparticles ranged from 2.96 +/- 0.05 to 5.61 +/- 0.19% in 1 g of chitosan nanopowder. Most significant antimicrobial effect was observed against the fungi Nannizzia fulva CCF 6025, where the MIC80 of the pure extract from Jonas 1 variety was 256 mu g/mL while the encapsulated extract in chitosan nanoparticles (1:10 w/w extract:chitosan ratio) inhibited growth at a concentration of 256 mu g/mL of nanoparticles (corresponding to 13.05 +/- 0.13 mu g/mL of extract). Overall, encapsulation reduced the amount of extract required to inhibit the growth of pathogenic microorganisms by up to several times, notably in case of dermatophytes, compared to non-encapsulated extracts. Encapsulation also reduced the cytotoxic effects of the extracts on human keratinocytes. Furthermore, pure high-THCA-A extract and encapsulated extract in chitosan nanoparticles slightly increased cell viability after 72 h exposure in low concentrations compared to control. These results may suggest the chitosan nanoparticles-encapsulated formulations as a suitable topical delivery form of cannabis extracts, offering a possible adjunctive treatment of dermatophytosis and wound healing., The author(s) declare that financial support was received for the research and/or publication of this article. The work used facilities provided by the METROFOOD-CZ Research Infrastructure (https://metrofood.cz), supported by the Ministry of Education, Youth and Sports of the Czech Republic (Project No. LM2023064). This research was supported by SGS project No. SV23-18-21310 and TACR Sigma -DC2 TQ03000678. The authors would like to acknowledge the support from the Spanish Ministry of Science and Innovation, AEI, and FEDER-EU (projects PID2021-128141OB-C22 and PID2021-126304OB-C41). AM-A thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). AL-L thanks the Spanish Government for his "Ramon y Cajal" Fellowship (RYC2021-034728-I).
Project:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-126304OB-C41
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-128141OB-C22
,
Agencia Estatal de Investigación PID2024-155683OB-C41
,
MEYS LM2023064
,
Agencia Estatal de Investigación RYC2021-034728-I